Thymosin Alpha-1 is an immunomodulatory peptide studied in infection and immune responses. Explore clinical trials, mechanisms, indication-specific evidence, and limitations.
Thymosin Alpha-1 is also described as thymalfasin or Tα1. It should not be confused with thymosin beta-4 or TB-500.
It is a 28-amino-acid peptide studied in immune regulation. A defined thymalfasin product and a research-labeled preparation are different materials.
Research examines innate and adaptive immune responses, including immune-cell function. Immunomodulation does not mean that every immune response is increased beneficially.
Clinical trials have evaluated specific illnesses, including sepsis. Findings depend on participant selection, concomitant care, trial design, and the endpoint measured.
Product authorization varies by jurisdiction and indication. Results from a clinical product cannot establish approval or effectiveness for unrelated formulations or general wellness use.
The ETASS randomized trial investigated thymosin alpha-1 alongside conventional care in severe sepsis. Its mortality estimate and immune-marker findings suggested further study rather than a definitive benefit for all patients. ETASS randomized trial
The later double-blind TESTS phase 3 trial found no conclusive evidence of reduced 28-day mortality in adults with sepsis. This larger trial is important context when assessing favorable claims based on earlier studies. TESTS phase 3 trial
Current programs, research areas, study status, enrollment, and expected completion dates organized from primary registry records.
Esophageal Cancer
Vaccine Response · COVID-19 Vaccine · Immune Response to Covid 19 Vaccination
Recurrent Implantation Faliure
Melanoma · Immune-related Adverse Event · Immune Checkpoint Inhibitor
Gastric Cancer · Esophagogastric Junction Adenocarcinoma
Thymosin alpha 1 lupus research is limited. Learn how this peptide may affect autoimmune conditions, safety concerns, and why you should talk to a doctor.
Thymosin alpha 1 injection uses in pregnancy are not established; learn what research shows, why safety data is limited, and what to discuss with your doctor.
Thymosin alpha-1 10mg vials explained: what the peptide is, how to reconstitute it, typical research dosing, side effects, and how it compares to TB-500.
How long does thymosin alpha 1 take to work? Learn typical timelines by use case, dosing factors, and what can speed up or slow down results.
Thymosin alpha 1 mechanism of action explained: how TLR2 and TLR9 binding triggers MyD88 signaling, dendritic cell maturation, and Th1 immune polarization.
Thymosin alpha 1 cystic fibrosis research is limited. Learn how this immunomodulatory peptide may affect CF, what studies show, and safety considerations.
Thymosin alpha 1 benefits may include immune support, T-cell function, and help with chronic infections. Learn what research shows, dosing, and safety.
Thymosin alpha 1 dosage in clinical studies is usually 1.6 mg subcutaneously twice weekly. Compare reported protocols, vial math, and safety notes.
Thymosin alpha 1 MCAS questions answered: how this immune peptide may affect mast cell activation, what research shows, and safety steps to discuss.
Thymosin alpha 1 and rheumatoid arthritis: what early research shows, how the peptide is studied, safety concerns, and why it is not an approved RA treatment.
See a thymosin alpha 1 dosage chart with typical research ranges, weight-based dosing math, and route comparisons, plus safety notes for US readers.
There is no FDA-approved thymosin alpha 1 COVID dosage. See the 1.6 mg regimens used in COVID-19 trials, how long they lasted, and what research shows.
Benefits of thymosin alpha 1 may include stronger T-cell activity, antiviral defense, and immune balance. Learn what research shows and safety details.
BPC 157 and thymosin alpha 1 are two research peptides studied for tissue repair and immune signaling. Compare mechanisms, dosing, and safety.
Thymosin alpha 1 and long COVID: what early research suggests about immune effects, dosing, safety, and why it is not FDA-approved for human use.
Thymosin alpha 1 side effects are usually mild, but injection-site reactions and immune responses can occur. Learn what research and clinical use show.
Thymosin alpha 1 vaccine: Learn why thymosin alpha 1 is not a vaccine but an immune peptide studied as a vaccine adjuvant, its benefits, side effects, dosage.
Jay Campbell discusses thymosin alpha 1 as an immune-modulating peptide. Here's what he says about dosing, benefits, sourcing, and overall safety.
Thymosin alpha 1 bodybuilding benefits are mostly indirect: it supports immune health, not muscle growth. Learn what research says, dosing, and side effects.
Thymosin alpha 1 vs TB500 compared: what each peptide does, how they differ, research status, dosing, legality, and safety in the United States.